Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children
© 2023. The Author(s)..
BACKGROUND: Respiratory syncytial virus (RSV) is the leading global cause of respiratory infections and is responsible for about 3 million hospitalizations and more than 100,000 deaths annually in children younger than 5 years, representing a major global healthcare burden. There is a great unmet need for new agents and universal strategies to prevent RSV infections in early life. A multidisciplinary consensus development group comprising experts in epidemiology, infectious diseases, respiratory medicine, and methodology aims to develop the current consensus to address clinical issues of RSV infections in children.
DATA SOURCES: The evidence searches and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, and the Cochrane Library, using variations in terms for "respiratory syncytial virus", "RSV", "lower respiratory tract infection", "bronchiolitis", "acute", "viral pneumonia", "neonatal", "infant" "children", and "pediatric".
RESULTS: Evidence-based recommendations regarding diagnosis, treatment, and prevention were proposed with a high degree of consensus. Although supportive care remains the cornerstone for the management of RSV infections, new monoclonal antibodies, vaccines, drug therapies, and viral surveillance techniques are being rolled out.
CONCLUSIONS: This consensus, based on international and national scientific evidence, reinforces the current recommendations and integrates the recent advances for optimal care and prevention of RSV infections. Further improvements in the management of RSV infections will require generating the highest quality of evidence through rigorously designed studies that possess little bias and sufficient capacity to identify clinically meaningful end points.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
World journal of pediatrics : WJP - 20(2024), 1 vom: 07. Jan., Seite 11-25 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Xian-Li [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Consensus prevention |
|---|
| Anmerkungen: |
Date Completed 31.01.2024 Date Revised 25.02.2024 published: Print-Electronic ErratumIn: World J Pediatr. 2024 Feb 25;:. - PMID 38402517 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12519-023-00777-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365548952 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365548952 | ||
| 003 | DE-627 | ||
| 005 | 20240229151516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12519-023-00777-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1305.xml |
| 035 | |a (DE-627)NLM365548952 | ||
| 035 | |a (NLM)38064012 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhang, Xian-Li |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.01.2024 | ||
| 500 | |a Date Revised 25.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: World J Pediatr. 2024 Feb 25;:. - PMID 38402517 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: Respiratory syncytial virus (RSV) is the leading global cause of respiratory infections and is responsible for about 3 million hospitalizations and more than 100,000 deaths annually in children younger than 5 years, representing a major global healthcare burden. There is a great unmet need for new agents and universal strategies to prevent RSV infections in early life. A multidisciplinary consensus development group comprising experts in epidemiology, infectious diseases, respiratory medicine, and methodology aims to develop the current consensus to address clinical issues of RSV infections in children | ||
| 520 | |a DATA SOURCES: The evidence searches and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, and the Cochrane Library, using variations in terms for "respiratory syncytial virus", "RSV", "lower respiratory tract infection", "bronchiolitis", "acute", "viral pneumonia", "neonatal", "infant" "children", and "pediatric" | ||
| 520 | |a RESULTS: Evidence-based recommendations regarding diagnosis, treatment, and prevention were proposed with a high degree of consensus. Although supportive care remains the cornerstone for the management of RSV infections, new monoclonal antibodies, vaccines, drug therapies, and viral surveillance techniques are being rolled out | ||
| 520 | |a CONCLUSIONS: This consensus, based on international and national scientific evidence, reinforces the current recommendations and integrates the recent advances for optimal care and prevention of RSV infections. Further improvements in the management of RSV infections will require generating the highest quality of evidence through rigorously designed studies that possess little bias and sufficient capacity to identify clinically meaningful end points | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Consensus prevention | |
| 650 | 4 | |a Respiratory syncytial virus | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a Zhang, Xi |e verfasserin |4 aut | |
| 700 | 1 | |a Hua, Wang |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Zheng-De |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Han-Min |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Hai-Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Bi-Quan |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yuan |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Shu, Sai-Nan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Shun-Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Shang, Yun-Xiao |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Ling |e verfasserin |4 aut | |
| 700 | 1 | |a Jia, Yan-Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Luo-Na |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Jiong |e verfasserin |4 aut | |
| 700 | 1 | |a Hao, Chuang-Li |e verfasserin |4 aut | |
| 700 | 1 | |a Dong, Xiao-Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Dao-Jiong |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Hong-Mei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, De-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Zeng, Mei |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Zhi-Min |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Li-Su |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of pediatrics : WJP |d 2008 |g 20(2024), 1 vom: 07. Jan., Seite 11-25 |w (DE-627)NLM178830402 |x 1867-0687 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2024 |g number:1 |g day:07 |g month:01 |g pages:11-25 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12519-023-00777-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2024 |e 1 |b 07 |c 01 |h 11-25 | ||